Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Calpis to increase Calsporin production

Tokyo-based Calpis is to increase the production capacity of its probiotic feed additive Calsporin from 180 tons to 300 tons per year, it has announced. It will spend Yen 500m (US$4.1m) on increasing the production capacity at its factory in Gunma, while production at its factory in Sagami will be discontinued in March to rationalize the business. The company expects global sales of Yen 3bn by 2010. Calpis received EU marketing approval for Calsporin, produced by live spore cells of Bacillus subtilis C-3102, last September.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts